脑部放疗，上午比下午敏感许多！
2 i( I. P8 h7 W0 j k7 e" Q# X7 K5 r2 i6 M* g" S/ k
! M$ B; }; \' s- P$ h. _
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.& o5 N6 r4 e6 M. D# h3 h7 ]$ Q. z
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
z( l6 F9 A1 V5 \* H- Y7 MRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.3 s' z2 h5 k/ e- ]6 A$ b) h
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA. C+ H* p& q" Y0 x9 F! I7 H5 c0 @3 H
* Y* V- j% p) s. G* z, Z
Abstract9 O& _ L, G7 S6 ?# S3 T
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
$ s( x c2 L8 X$ w8 E2 g2 F- P, f% j5 b
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.) M! b7 Z8 A6 o6 F
- V/ f0 I$ l" w5 ^. @* Z! N. {3 b$ t
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
/ X( d: b, G2 w2 P
: i8 x0 z* _; f% J) _8 S* m5 t7 D! uCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
+ K7 u1 Z. B5 }) N* z% e
; W$ G& q) g7 i& ? |
显身卡
